AstraZeneca Australia

We push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve this is to put science at the centre of everything we do.

AstraZeneca’s response to the COVID-19 pandemic

AstraZeneca abides by Medicines Australia’s Code of Conduct and the Therapeutic Goods Act which limit the information that can be provided by a pharmaceutical company to the general public on prescription medicines.  The Australian Government is responsible for all rollout and implementation of COVID-19 vaccinations in Australia.  If you are seeking information on COVID-19 or COVID-19 vaccines please visit the Australian government website: https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines

Updated ATAGI advice on COVID-19 Vaccine AstraZeneca in response to Delta outbreaks

Recognition of locally-manufactured COVID-19 Vaccine AstraZeneca

  • Who we are

    AstraZeneca Australia is part of the global science-led biopharmaceutical company, AstraZeneca. We are engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians.

  • What we do

    We focus on three main therapeutic areas; Oncology; Respiratory, Inflammation and Autoimmunity (RIA); Cardiovascular and Metabolic Diseases (CVMD). We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 50 years, and our vision is to make the most meaningful difference to the lives of Australian patients ensuring Australians have access to our innovative medicines. We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.

  • Our purpose and values

    Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.

Our business strategy

We are focused on returning to growth through science-led innovation

  • Achieve scientific leadership

    We are focusing our science on our main therapy areas and accelerating our pipeline. We are also transforming our way of working.

    Read More

  • Return to growth

    We are focusing on our growth platforms and transforming the business through specialty care, devices and biologics. Targeted business development reinforces our efforts.

    Read more

  • Be a great place to work

    We are evolving our culture and simplifying our business. We want to attract and retain the best talent.

    Read more